TGRX-3247

N/A

Report date: 2024/12/26 11:35:31
NME

Base Information

Drug NameTGRX-3247
Drug Alias NameTGRX-3247
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionABL proto-oncogene 1 degraders
TargetsABL proto-oncogene 1
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShenzhen TargetRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen TargetRx Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A